The NASEM report on improving representation in clinical trials outlines the high cost of care and poor patient outcomes that are a consequence of not increasing diversity in research.
SWHR will oversee the Coalition to Advance Maternal Therapeutics (CAMT), a coalition founded in 2014 to increase inclusion of pregnant and lactating populations in clinical research.
During the July 26, 2022, “Taking Heed of Alzheimer’s Disease" briefing, disease stakeholders discussed research and treatment for AD and its disproportionate impact on women.
SWHR gathered psoriatic arthritis health care providers, researchers, patients and patient advocates in June 2022 to discuss the health, social, and economic impacts of PsA on women’s health across the lifespan.
A commentary paper in the Biology of Sex Differences journal reviews the state of sex differences research in the human brain.
This commentary on skin disease burden in the journal Women’s Health Issues aims to advance understanding and awareness of autoimmune skin diseases in women.
SWHR's Gynecologic Health Network meeting in June 2022 covered the connections between endometriosis and pelvic pain and abnormal sleep in women.
This June 2022 Working Group gathered clinicians, researchers, patients and patient advocates, and policy leaders for a discussion on gaps and opportunities in lupus care for women.
Responsum Health and SWHR entered a partnership to expand content for the Responsum for Fibroids app, a free mobile app for women challenged with uterine fibroids.
The Menopause Preparedness Toolkit can help support women through the menopause transition and prepare them for menopause conversations with physicians, families, and friends.